These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 22971274)
1. Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer. Agarwal S; Gertler FB; Balsamo M; Condeelis JS; Camp RL; Xue X; Lin J; Rohan TE; Rimm DL Breast Cancer Res; 2012 Sep; 14(5):R124. PubMed ID: 22971274 [TBL] [Abstract][Full Text] [Related]
2. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. Forse CL; Agarwal S; Pinnaduwage D; Gertler F; Condeelis JS; Lin J; Xue X; Johung K; Mulligan AM; Rohan TE; Bull SB; Andrulis IL BMC Cancer; 2015 Jun; 15():483. PubMed ID: 26112005 [TBL] [Abstract][Full Text] [Related]
3. Mena invasive (Mena(INV)) and Mena11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Roussos ET; Goswami S; Balsamo M; Wang Y; Stobezki R; Adler E; Robinson BD; Jones JG; Gertler FB; Condeelis JS; Oktay MH Clin Exp Metastasis; 2011 Aug; 28(6):515-27. PubMed ID: 21484349 [TBL] [Abstract][Full Text] [Related]
4. The alternatively-included 11a sequence modifies the effects of Mena on actin cytoskeletal organization and cell behavior. Balsamo M; Mondal C; Carmona G; McClain LM; Riquelme DN; Tadros J; Ma D; Vasile E; Condeelis JS; Lauffenburger DA; Gertler FB Sci Rep; 2016 Oct; 6():35298. PubMed ID: 27748415 [TBL] [Abstract][Full Text] [Related]
5. Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Di Modugno F; Iapicca P; Boudreau A; Mottolese M; Terrenato I; Perracchio L; Carstens RP; Santoni A; Bissell MJ; Nisticò P Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19280-5. PubMed ID: 23129656 [TBL] [Abstract][Full Text] [Related]
6. Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. Roussos ET; Balsamo M; Alford SK; Wyckoff JB; Gligorijevic B; Wang Y; Pozzuto M; Stobezki R; Goswami S; Segall JE; Lauffenburger DA; Bresnick AR; Gertler FB; Condeelis JS J Cell Sci; 2011 Jul; 124(Pt 13):2120-31. PubMed ID: 21670198 [TBL] [Abstract][Full Text] [Related]
7. Signatures of Breast Cancer Metastasis: aMENAble to Interpretation? Oudin MJ; Gertler FB Trends Cancer; 2017 Jan; 3(1):7-9. PubMed ID: 28718427 [TBL] [Abstract][Full Text] [Related]
8. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer. Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473 [TBL] [Abstract][Full Text] [Related]
10. Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Goswami S; Philippar U; Sun D; Patsialou A; Avraham J; Wang W; Di Modugno F; Nistico P; Gertler FB; Condeelis JS Clin Exp Metastasis; 2009; 26(2):153-9. PubMed ID: 18985426 [TBL] [Abstract][Full Text] [Related]
11. Quantitative assessment of miR34a as an independent prognostic marker in breast cancer. Agarwal S; Hanna J; Sherman ME; Figueroa J; Rimm DL Br J Cancer; 2015 Jan; 112(1):61-8. PubMed ID: 25474246 [TBL] [Abstract][Full Text] [Related]
12. hMENA(11a) contributes to HER3-mediated resistance to PI3K inhibitors in HER2-overexpressing breast cancer cells. Trono P; Di Modugno F; Circo R; Spada S; Di Benedetto A; Melchionna R; Palermo B; Matteoni S; Soddu S; Mottolese M; De Maria R; Nisticò P Oncogene; 2016 Feb; 35(7):887-96. PubMed ID: 25961924 [TBL] [Abstract][Full Text] [Related]
13. MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer. Oudin MJ; Barbier L; Schäfer C; Kosciuk T; Miller MA; Han S; Jonas O; Lauffenburger DA; Gertler FB Mol Cancer Ther; 2017 Jan; 16(1):143-155. PubMed ID: 27811011 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the expression of the pro-metastatic Mena(INV) isoform during breast tumor progression. Oudin MJ; Hughes SK; Rohani N; Moufarrej MN; Jones JG; Condeelis JS; Lauffenburger DA; Gertler FB Clin Exp Metastasis; 2016 Mar; 33(3):249-61. PubMed ID: 26680363 [TBL] [Abstract][Full Text] [Related]
17. Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma. Tanaka N; Yoshida H; Suzuki Y; Harigaya K Int J Oncol; 2014 Nov; 45(5):1921-8. PubMed ID: 25109497 [TBL] [Abstract][Full Text] [Related]
18. High nuclear MSK1 is associated with longer survival in breast cancer patients. Pu X; Storr SJ; Ahmad NS; Rakha EA; Green AR; Ellis IO; Martin SG J Cancer Res Clin Oncol; 2018 Mar; 144(3):509-517. PubMed ID: 29327245 [TBL] [Abstract][Full Text] [Related]
19. The possible role of Mena protein and its splicing-derived variants in embryogenesis, carcinogenesis, and tumor invasion: a systematic review of the literature. Gurzu S; Ciortea D; Ember I; Jung I Biomed Res Int; 2013; 2013():365192. PubMed ID: 23956979 [TBL] [Abstract][Full Text] [Related]
20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer. Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]